Our TÜBİTAK 1001 project has been awarded

January 20, 2026

We are pleased to share that our TÜBİTAK 1001 project has been awarded funding.

Within the scope of this project, we will investigate the therapeutic potential of circadian rhythm proteins in pancreatic cancer, in collaboration with Derya Bakırdögen. 🔬 ⏰ 💊

We would like to congratulate our entire research team and all collaborating partners for their contributions. 👏